AbbVie (ABBV) Dividend Yield & History

ABBV$294.98+1.09 +0.37%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$521.41BEnterprise value$591.13BRevenue (TTM)$66.01BMarket positionTop 5%

Score

56
Neutral
Value
35
Quality
73
Growth
59
$294.98Price
$521.41BMarket cap
50.19P/E
18.59Forward P/E
2.32%Dividend yield

Yield is based on dividends paid in the past 12 months. 2026 isn't counted in streaks until the year ends.

$294.98 buys AbbVie Inc., which paid $6.83 a share over the past year, a 2.32% yield.

Each year from 2013 through 2025, the AbbVie dividend was higher.

A quarterly increase on 16 January 2026 took AbbVie from $1.64 to $1.73, up 5.5%.

Over the past year, dividends were 117% of earnings at AbbVie.

AbbVie distributes its dividend each quarter.

Next ex-dividend date for AbbVie: 15 January 2027. Pay date: 16 February 2027.

The five-year growth rate of the AbbVie dividend is 6.8% a year.

Our records cover 57 payments from 2013 to 2026.

At today's yield, $10,000 invested would receive about $232 a year in dividends before tax, if payments stay the same. Dividends can be cut.

Learn: How to read a dividend

Full ABBV quote · Forecast · Academy

Questions

When did ABBV last raise the dividend?

$1.64 was followed by $1.73 on 16 January 2026.

How often does ABBV pay a dividend?

AbbVie shareholders were paid 4 times in the past year.

How many years has ABBV raised the dividend?

Back to 2013, every year was higher. 2025 was $6.56.

What is the ABBV dividend yield?

ABBV is on a 2.32% dividend yield.

How long after the ABBV ex-dividend date is the cash paid?

32 days.

AbbVie (ABBV) Dividend Yield & History

ABBV price $294.98 +1.09 +0.37%

Ticker
ABBV
Price
$294.98
Change
+1.09 +0.37%
Market cap
$521.41B
P/E
50.19
Forward P/E
18.59
Dividend yield
2.35%
Beta
0.28
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
56
Value
35
Quality
73
Growth
59

Stocklytics score rationale: value 35, quality 73, growth 59.

AI Score 70. AbbVie Inc. has a strong market capitalization of $505.4 billion and a solid gross profit margin of approximately 76.3%

Summary

AbbVie Inc. operates in the Healthcare sector and Drug Manufacturers - General industry. The company reports a net margin of 15.7% and a dividend yield of 2.4%.

Valuation

The shares trade at a P/E ratio of 50.6, which is a key valuation input but cannot be assessed against peers or history from the provided facts. Price-to-book is -88.0, limiting its usefulness as a conventional valuation measure.

Quality

A net margin of 15.7% indicates the company generated positive reported profitability. The negative price-to-book figure of -88.0 suggests book-value-based analysis requires caution.

Growth

No revenue, earnings-growth, estimate-revision, or price-trend data is provided. Growth cannot be evaluated from the available facts.

Risks

The P/E ratio of 50.6 may leave the shares sensitive to changes in earnings expectations. Negative price-to-book of -88.0 also makes balance-sheet valuation interpretation less straightforward.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener